No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Capecitabine
-
Chemotherapy, Adjuvant
-
Colectomy
-
Colonoscopy
-
Colorectal Neoplasms / diagnosis*
-
Colorectal Neoplasms / pathology
-
Colorectal Neoplasms / prevention & control
-
Colorectal Neoplasms / therapy*
-
Combined Modality Therapy
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / adverse effects
-
Deoxycytidine / analogs & derivatives
-
Endosonography
-
Fluorouracil / administration & dosage
-
Fluorouracil / adverse effects
-
Fluorouracil / analogs & derivatives
-
Humans
-
Liver Neoplasms / diagnosis
-
Liver Neoplasms / pathology
-
Liver Neoplasms / secondary
-
Liver Neoplasms / therapy
-
Mass Screening*
-
Metastasectomy
-
Multimodal Imaging
-
Neoplasm Staging
-
Occult Blood
-
Organoplatinum Compounds / administration & dosage
-
Organoplatinum Compounds / adverse effects
-
Oxaliplatin
-
Phenylurea Compounds / administration & dosage
-
Phenylurea Compounds / adverse effects
-
Positron-Emission Tomography
-
Practice Guidelines as Topic
-
Pyridines / administration & dosage
-
Pyridines / adverse effects
-
Salvage Therapy
-
Tomography, X-Ray Computed
Substances
-
Organoplatinum Compounds
-
Phenylurea Compounds
-
Pyridines
-
Oxaliplatin
-
Deoxycytidine
-
regorafenib
-
Capecitabine
-
Fluorouracil